News Release excerpt provided by PR Newswire.
With the support of a $3 million Ohio Third Frontier Innovation Platform Program grant, Synapse Biomedical Inc. will lead the commercialization of third generation neurostimulation technology pioneered by Professor Hunter Peckham and his team at Case Western Reserve University (CWRU). Synapse Biomedical has also brought in global partners to assist in the collaboration with CWRU and its non-profit Institute for Functional Restoration (IFR).
Case Western Reserve, Synapse Biomedical, The University of Tokyo and Cleveland-based Valtronic will match the funding as they move forward. Synapse Biomedical will produce and market the systems after the technology earns CE Mark, PMDA (Japanese) and FDA approvals.
“Synapse is proud to be part of this endeavor under the funding of the Third Frontier from the State of Ohio,” said Tim Crish, VP of Product Development and Operations at Synapse. “We have already been able to save engineering jobs that were being relocated out of state from another company closure as we kicked off this project. This will help continue the leadership of the region in neurostimulation.”
Click here to read the complete release.
Read more in Crain’s Cleveland Business.
Originally published October 15, 2015.